Response to Grech et al.: FLOUX-PMS study sample considerations

Mult Scler. 2019 Nov;25(13):1820-1821. doi: 10.1177/1352458519876027. Epub 2019 Sep 20.

Authors

Jop P Mostert¹, Jacques De Keyser^{2

3

4}

Affiliations

¹ Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands.
² Department of Neurology, UZ Brussel, Brussel, Belgium.
³ Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
⁴ Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

PMID: 31538547
DOI: 10.1177/1352458519876027

No abstract available

Publication types

Comment

MeSH terms

Demyelinating Diseases*
Fluoxetine
Humans
Multiple Sclerosis*

Substances

Fluoxetine